Friday Frontiers in Biomedical Science
Friday Frontiers in Biomedical Science is designed to engage researchers and clinicians at all stages of career development. The upcoming seminar features three T32 Integrative Cancer Scholars, medical and doctoral candidate Julia Morris, doctoral candidate Allison Moreno Samayoa, and doctoral Candidate Isabelle Tobey. The three speakers will share a 15-minute overview of their work, with an opportunity for audience engagement.
Light refreshments will be provided.
Title: Impact of human papillomavirus on the cyclic GMP–AMP synthase – stimulator of interferon genes (cGAS/STING) pathway
Tobey is in her third year of the Cancer Biology program. She graduated from Hampshire College in 2018 with a degree in molecular biology of cancer. Tobey then worked as a research associate at the Broad Institute in their viral vector engineering lab until 2020 when she joined the Arizona Biological and Biomedical Sciences program. She is now a member of the Campos and Van Doorslaer labs.
Title: The identification and characterization of folinic acid, fluorouracil and oxaliplatin (FOLFOX) resistant cell lineages in colorectal cancer
Morris is an medical and doctoral candidate from the Department of Cellular and Molecular Medicine. Morris' research examines nongenetic mechanisms of chemotherapy resistance and the development of phenotypic biomarkers, all with a focus on colorectal cancer. She is interested in translational medicine and investigating ways to improve cancer therapy outside of drug development.
Title: Sulfur amino acid deprivation and N-acetyl cysteine induce cell death in breast cancer
Moreno Samayoa earned her bachelor's degree from Cornell College in Mount Vernon, Iowa. She then participated in the Post-Baccalaureate Research Education Program PREP at the University of Iowa before joining the Arizona Biological and Biomedical Sciences doctoral program in 2018. Moreno Samayoa then joined the Cancer Biology Graduate Interdisclipinary Program and the lab of Dr. Andrew Paek where she uses live cell microscopy to study the effect of sulfur amino acid deprivation on breast cancer cells.